3-Butylidenephthalide is a gamma-lactone isolated from Angelica sinensis, which is used to treat anemia and gynecological dysfunction in traditional Chinese medicine. 3-Butylidenephthalide is a natural liposoluble compound with a low molecular weight that possesses multiple pharmacological activities, such as reducing injury and fibrosis in the liver and neuroprotective activity. 3-Butylidenephthalide exerts cytotoxic or inhibitory effects on various cancers, including brain, lung, colon, prostate, and liver cancers.
Approval Year
Substance Class |
Mixture
Created
by
admin
on
Edited
Sat Dec 16 12:50:40 GMT 2023
by
admin
on
Sat Dec 16 12:50:40 GMT 2023
|
Record UNII |
S9178G4B3F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
485715
Created by
admin on Sat Dec 16 12:50:40 GMT 2023 , Edited by admin on Sat Dec 16 12:50:40 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1161
Created by
admin on Sat Dec 16 12:50:40 GMT 2023 , Edited by admin on Sat Dec 16 12:50:40 GMT 2023
|
PRIMARY | |||
|
C026105
Created by
admin on Sat Dec 16 12:50:40 GMT 2023 , Edited by admin on Sat Dec 16 12:50:40 GMT 2023
|
PRIMARY | |||
|
208-991-3
Created by
admin on Sat Dec 16 12:50:40 GMT 2023 , Edited by admin on Sat Dec 16 12:50:40 GMT 2023
|
PRIMARY | |||
|
68233
Created by
admin on Sat Dec 16 12:50:40 GMT 2023 , Edited by admin on Sat Dec 16 12:50:40 GMT 2023
|
PRIMARY | |||
|
325307
Created by
admin on Sat Dec 16 12:50:40 GMT 2023 , Edited by admin on Sat Dec 16 12:50:40 GMT 2023
|
PRIMARY | |||
|
S9178G4B3F
Created by
admin on Sat Dec 16 12:50:40 GMT 2023 , Edited by admin on Sat Dec 16 12:50:40 GMT 2023
|
PRIMARY | |||
|
551-08-6
Created by
admin on Sat Dec 16 12:50:40 GMT 2023 , Edited by admin on Sat Dec 16 12:50:40 GMT 2023
|
PRIMARY |